|
Delayed
NSE India S.E.
04:14:16 2026-09-16 EDT
|
5-day change | 1st Jan Change | ||
| 1,360.00 INR | +0.67% |
|
-0.29% | -10.06% |
| 09-03 | India's Cipla, China's Qilu partner for US launch of Merck's Keytruda biosimilar | RE |
| 08-25 | Cipla's Pithampur, India Unit Gets 7 Observations From US FDA | MT |
ETFs positioned on Cipla Limited
| Name | YTD change | Weight | AuM | |
|---|---|---|---|---|
 | +11.35% | -.--% | 27,154 M€ | |
| +13.14% | -.--% | 1,674 M€ | |
| +6.32% | -.--% | 37 M€ | |
| +10.12% | -.--% | 67 M€ | |
| +19.11% | -.--% | 9,273 M€ | |
| -12.05% | 2.13% | 118 M€ | |
| -17.47% | 1.26% | 125 M€ | |
| -14.25% | 1.12% | 48 M€ | |
| -20.73% | 0.76% | 124 M€ | |
| +22.44% | 0.75% | 122 M€ | |
| -10.64% | 0.72% | 6 M€ | |
| +46.49% | 0.72% | 18 M€ | |
| -13.86% | 0.71% | 96 M€ | |
| -13.43% | 0.69% | 5,254 M€ | |
| -12.67% | 0.68% | 2 M€ | |
| -21.53% | 0.66% | 108 M€ | |
| -15.13% | 0.66% | 565 M€ | |
| -11.95% | 0.55% | 6,661 M€ | |
| +17.58% | 0.54% | 86 M€ | |
| +16.12% | 0.53% | 3,601 M€ | |
| +17.07% | 0.52% | 491 M€ | |
| -11.26% | 0.51% | 99 M€ | |
| +29.21% | 0.49% | 68 M€ | |
| -9.15% | 0.47% | 2,189 M€ | |
| -11.17% | 0.46% | 2,692 M€ | |
| +28.10% | 0.45% | 148 M€ | |
| -7.62% | 0.45% | 49 M€ | |
| -10.63% | 0.4% | 2,054 M€ | |
| -11.58% | 0.37% | 5 M€ | |
| +21.15% | 0.28% | 60 M€ | |
| +11.71% | 0.27% | 1,125 M€ | |
| +18.90% | 0.26% | 180 M€ | |
| +22.11% | 0.25% | 164 M€ | |
| +6.97% | 0.25% | 1,545 M€ |
Employees
31,369
Sector
Pharmaceuticals
- Stock Market
- Stocks
- CIPLA Stock
- ETFs Cipla Limited
Select your edition
All financial news and data tailored to specific country editions
